聯合健康季績優 重組順利助撐起股價

Along the whole industry, due to COVID related expense and other mismanagement issues past 2-3 years, UnitedHealth have experienced higher medical cost.  Despite solid efforts to control cost which still need more time to work out, the firm’s medical loss ratio stayed high at 89.9% last quarter; although inline with expectation, it is much higher than the low-80% UnitedHealth and the sector target for.  Although the company is on early track to control medical expense by lowering number of its Optum Health clinics and doctor network, it may take another 2-3 quarters to see bigger recovery of profit margin.

Improving profit margin and slightly higher customer number could help UnitedHealth to increase its 2026 profit to meet or exceed current average analyst forecast of US$17.59 per share for a roughly 8.2% YOY growth from the estimated EPS of US$16.20 this year.  This would be solid evidence the insurer is turning around and this positive momentum may sustain to accelerate growth rate to 10% or higher in 2027 to see a US$20 EPS.  That would alleviate market worry and show that it is recovering from past 2-3 years problem and should not suffer from major derating in valuations.

頁次: 1 2 3 4 5 6